Please login to the form below

Not currently logged in

People, August, 2005

PriceSpective, an international pharmaceutical pricing strategy consultancy, has appointed Donald Macarthur as senior consultant.

PriceSpective, an international pharmaceutical pricing strategy consultancy, has appointed Donald Macarthur as senior consultant. Donald has over 40 years' pharmaceutical experience, most recently as secretary general of the European Association of Euro-Pharmaceutical Companies. He has written 46 major business reports and in 1996 established Pharma Pricing Review.

Neil McGregor-Paterson has been appointed to the newly-created role of strategic planning director of Weber Shandwick's healthcare practice. Neil, who has worked with agencies in the UK and US, including Shire Health and Ogilvy PR, joins the team to support new business and drive strategic planning for the agency's healthcare clients. He began his career as a medical rep for the Wellcome Foundation and worked in community affairs and public affairs for GlaxoWellcome.

Dr AgustÌn de la Calle has joined French biopharma company Innate Pharma as head of business development. Dr de la Calle will primarily be responsible for initiating and maintaining partnerships with the pharmaceutical industry. He comes to Innate after serving as director of business development at antibody-based drug discovery firm, Micromet AG in Germany. Previously, he served as a scientist at Eos Biotechnology.

Specialist healthcare group Ark Therapeutics has named Dr Bruce Carter as a non-executive director and member of Ark's remuneration committee. Dr Carter is currently president and chief executive officer of pharmaceutical company ZymoGenetics and is on a number of pharma boards including Epigemomics, which focuses on improving the prognosis of patients with cancer and other common diseases. Prior to his role at ZymoGenetics, Dr Carter was corporate executive VP and CSO of Novo Nordisk.

Anne Hyder has joined Manning Selvage & Lee in London (MS&L) as director of international healthcare. Anne comes from MS&L in San Francisco where she was director of the health practice. She has been a senior level consultant to a number of biotech, pharma and medical technology firms. She has also specialised in various disease areas including, oncology, diabetes, ophthalmology medical imaging, and health systems and hospitals.

Peter Martin, chief operating officer at Norgine has been elected chair of the European Medicines Group (EMG) for a one-year term. The EMG develops and supplies prescription medicines to the NHS. He joined Norgine in May 2004 and since then has also been appointed to the Association of the British Pharmaceutical Industry board of management.

Baxter Healthcare has made three new appointments to its UK haemophilia team. David Youds joins as business unit manager, where he will be responsible for all haemophilia sales and marketing activities in the UK. Previously, he was the regional business unit head for transplantation and immunology, in the Nordic region for Novartis Pharma. Meanwhile, Janet Sandy joins Baxter as strategic therapy development manager for biopharma. Her prime responsibility will be market development activities, which include KOL responsibilities for antibody therapy and haemophilia. Craig Dixon has been promoted to group product manager, haemophilia with responsibility for all product marketing in the area. He was previously senior product manager for Advate.


hsdcommunications has promoted Carol Singleton to the position of account manager. As well as continuing to manage the Primary Care dermatology Society Secretariat business, Carol will also be working with the account team for new client, the Primary Care Society for Gastroenterology.

Chiltern International has appointed Steven Dilworth as an internal recruiter. Steven, who joins the integrated resourcing team, will initially focus on clinical research associate, clinical trial administrator and data management roles. Bridget Smith has joined the US business development team at Chiltern International. Her role will be to work with clients throughout the South East region. Previously, she worked in the government affairs department at Glaxo before going into sales.

Karlien Ferreira has joined The Harten Group as projects coordinator. She will have responsibility for a number of projects across the group, including advisory board liaison, working with clients' strategic outsourcing initiatives. and managing the move to new premise.

Insight Research Group has promoted Helen Porter to the post of research director. Helen joined Insight in 1999 and has since gained experience in both international and UK domestic healthcare marketing research.

Connectmedical has made four new appointments. Julia Morris joins as editor. She has four years' writing and editing experience and will provide editorial services for educational projects. Glynis Sutton will be project manager for Guidelines and Guidelines in Practice medical education initiatives. Sherief Hassan will be in charge of the production of workshops, awards and conferences while Mona Munonyara joins as assistant editor working on medical education initiatives.

Zaicom Medical Marketing Communications has hired Julian Ball as senior medical writer and Sally Hyett as a project coordinator with a particular specialism in design and production. Julian joins Zaicom MMC from Wells Healthcare Communications. Sally has eight years' logistics management experience and previously worked in the travel industry.

Spectrum Regulatory Solutions, a subsidiary of Zaicom International, has made two new appointments: Dr Angela Gisby joins as head and director while Dr Anneli Conway joins as team leader of editorial services.

Creative Lynx has added two new designers: Matthew Robinson joins as a middleweight designer while Matt Hall becomes the company's newest junior designer.

Virgo Health PR has made four new appointments: Lisa Rodwell joins the team as account director. Lisa will be providing senior support for the OTC/consumer health portfolio and joins from Munro & Forster, where she was responsible for the strategic development and management of PR programmes for Pfizer Consumer Healthcare brands. Tara Breen joins as senior account manager and will be working on both UK and global programmes for osteoporosis drug Bonviva, on behalf of Roche and GSK. Tara was previously at Hill & Knowlton where she spent over three years specialising in women's healthcare and oncology. Ian McDermott joins Virgo as account manager from Weber Shandwick. He will be working on a number of UK and international accounts including Bonviva and Lilly's ADHD drug, Strattera. Emily Brooks joins as junior account executive; she will be working on Bonviva and GSK's Type 2 diabetes drug, Avandamet. has made five new appointments: Dave Pinnington joins as business development director for pharmaceutical marketing. He was previously at Activity Benchmarking, where he was responsible for sales and marketing services. Phil Earl has been named finance director. His last position before joining the company was in the commercial finance team of Xansa. Pete Marshall joins the company as product development manager. Pete previously worked for Abbott Diabetes Care. John Hyder joins as market analyst. He has worked in IT for 10 years. Carla Aerts joins as account manager for the public sector. Carla was a member of a number of blue chip digital task forces and boards and has worked with Johnson & Johnson, Janssen Pharmaceutica, Janssen-Cilag and NHSDirect.


Subscribe to our email news alerts

Featured jobs


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Shaping the dermatology landscape: Independent expert analysis of the pipeline in 5 disease areas
Leading dermatologists discuss the innovations shaping 5 chronic skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa—and share the challenges and opportunities for biopharmaceutical companies developing innovative treatments....
Keith Berelowitz
Transforming clinical trials to accelerate drug development
How the WHO hepatitis strategy measures up in the field
With hepatitis cases on the rise, Dr Anthony Martinez, member of the International Hepatitis Education Program (IHEP), shares his perspective on the World Health Organization’s new strategy for hepatitis elimination...